ATE238051T1 - Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen - Google Patents

Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen

Info

Publication number
ATE238051T1
ATE238051T1 AT99926687T AT99926687T ATE238051T1 AT E238051 T1 ATE238051 T1 AT E238051T1 AT 99926687 T AT99926687 T AT 99926687T AT 99926687 T AT99926687 T AT 99926687T AT E238051 T1 ATE238051 T1 AT E238051T1
Authority
AT
Austria
Prior art keywords
vitamin
esters
vulvitis
topical treatment
mucous membrane
Prior art date
Application number
AT99926687T
Other languages
English (en)
Inventor
Giorgio Panin
Eleonora Annunziata
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE238051(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Application granted granted Critical
Publication of ATE238051T1 publication Critical patent/ATE238051T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99926687T 1998-07-10 1999-07-05 Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen ATE238051T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (1)

Publication Number Publication Date
ATE238051T1 true ATE238051T1 (de) 2003-05-15

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99926687T ATE238051T1 (de) 1998-07-10 1999-07-05 Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen

Country Status (22)

Country Link
EP (1) EP1094807B1 (de)
JP (1) JP2002520281A (de)
CN (1) CN1135975C (de)
AT (1) ATE238051T1 (de)
AU (1) AU762860B2 (de)
BR (1) BR9911945A (de)
CA (1) CA2336990A1 (de)
CZ (1) CZ301019B6 (de)
DE (1) DE69907193T2 (de)
DK (1) DK1094807T3 (de)
ES (1) ES2196813T3 (de)
HU (1) HU228921B1 (de)
IL (1) IL140759A0 (de)
IT (1) ITMI981586A1 (de)
NO (1) NO20006719L (de)
NZ (1) NZ509129A (de)
PL (1) PL345500A1 (de)
PT (1) PT1094807E (de)
RU (2) RU2221561C2 (de)
SK (1) SK284464B6 (de)
TR (2) TR200100014T2 (de)
WO (1) WO2000002554A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US8722728B2 (en) 2008-10-09 2014-05-13 Ramscor, Inc. Composition and method for treating dry eye syndrome
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
CA2805511C (en) * 2009-07-27 2017-04-11 Sanseverino, Renato Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
MX340951B (es) 2011-09-29 2016-07-29 Plx Pharma Inc Portadores dependientes del ph para la liberacion dirigida de productos farmaceuticos a lo largo del tracto gastrointestinal, composiciones de los mismos, y fabricación y uso de las mismas.
KR20150024888A (ko) * 2012-06-08 2015-03-09 더 오하이오 스테이트 유니버시티 토코트리에놀을 사용한 화상 및 흉터 상해 치료
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
LT3209294T (lt) * 2014-10-22 2019-10-25 Bio Lo Ga Srl Farmacinė kompozicija, skirta panaudoti nosies gleivinės trofizmo padidinimui
WO2016146843A1 (en) * 2015-03-18 2016-09-22 Bionoox Suisse Sa Compositions comprising dihydroquercetin for use in methods for treating herpes
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
US11576926B2 (en) * 2018-09-12 2023-02-14 Neilos S.r.l. Composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
WO2021195319A1 (en) 2020-03-26 2021-09-30 Plx Opco Inc. PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND- METHODS FOR MAKING AND USING SAME

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
SK284464B6 (sk) 2005-04-01
DE69907193D1 (de) 2003-05-28
TR200103710T2 (tr) 2002-06-21
RU2003128023A (ru) 2005-04-10
JP2002520281A (ja) 2002-07-09
RU2221561C2 (ru) 2004-01-20
HUP0102781A3 (en) 2002-04-29
NZ509129A (en) 2003-10-31
ITMI981586A0 (it) 1998-07-10
ITMI981586A1 (it) 2000-01-10
SK352001A3 (en) 2001-06-11
HUP0102781A2 (hu) 2001-12-28
WO2000002554A1 (en) 2000-01-20
PT1094807E (pt) 2003-08-29
TR200100014T2 (tr) 2001-06-21
CZ200136A3 (cs) 2001-08-15
CA2336990A1 (en) 2000-01-20
BR9911945A (pt) 2001-03-27
IL140759A0 (en) 2002-02-10
CZ301019B6 (cs) 2009-10-14
DE69907193T2 (de) 2004-04-08
NO20006719L (no) 2001-02-16
DK1094807T3 (da) 2003-08-11
PL345500A1 (en) 2001-12-17
CN1135975C (zh) 2004-01-28
EP1094807A1 (de) 2001-05-02
HU228921B1 (en) 2013-06-28
AU4385899A (en) 2000-02-01
CN1308531A (zh) 2001-08-15
ES2196813T3 (es) 2003-12-16
AU762860B2 (en) 2003-07-10
EP1094807B1 (de) 2003-04-23
NO20006719D0 (no) 2000-12-29

Similar Documents

Publication Publication Date Title
ATE238051T1 (de) Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen
NO20044699L (no) Vaginalpleiesammensetning
DE50208008D1 (de) Tiotropiumsalze zur behandlung von entzündlichen erkrankungen
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
ME01310B (me) Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa-1-gama aktivatori u lečenju dijabetesa
ES2182915T3 (es) Procedimiento de purificacion del factor viii
DE69526183D1 (de) 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen
EA200400881A1 (ru) Азаарилпиперазины
ATE470446T1 (de) Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
ATE451123T1 (de) Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie
ATE350011T1 (de) Pharmazeutische zusammensetzung zur behandlung von ulzerationen und/oder erosionen des schleimhautepithels
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
AU2003225131A1 (en) 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo' b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE345123T1 (de) Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten
UA83081C2 (ru) Лечебное средство на основе меда, его применение и способ его получения
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE270098T1 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
NO20003931L (no) Hydroksam- og karboksylsyrederivater
ITMI991144A1 (it) Acido tricloroacetico per la preparazione di soluzioni e/o composizioni per il trattamento di lesioni erosive e/o ulcerative
RU2160604C1 (ru) Способ лечения урогенитальных инфекций
RU2000106782A (ru) Применение препарата "юницивин" для лечения воспалительных процессов в матке женщин

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1094807

Country of ref document: EP